Hypertrophic and anabolic signals activated by AAS (e.g., via the Akt/mammalian target of rapamycin (mTOR) pathway) may inhibit autophagy in cardiomyocytes, similarly to other models of cardiac hypertrophy unrelated to AAS [37,38,39]. Here, MTOR is linked to cardiac hypertrophy.